Publications - Page 17 sur 43 - RespiFIL - Filière de santé des maladies respiratoires rares

Voici les publications scientifiques relatives aux maladies respiratoires rares auxquelles les membres de la filière ont contribué, classées par groupes de pathologies (depuis juillet 2021).

Hypertension pulmonaire (HTP) 31/08/23
Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.

Saint-Martin Willer A, Santos-Gomes J, Adão R, Brás-Silva C, Eyries M, Pérez-Vizcaino F, Capuano V, Montani D, Antigny F.

J Physiol. 2023 Jul 21.
Hypertension pulmonaire (HTP) 31/08/23
Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.

Kularatne M, Eyries M, Savale L, Humbert M, Montani D.

Chest. 2023 Aug;164(2):e23-e26.
Fibrose pulmonaire - FPI 31/08/23
French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version.

Cottin V, Bonniaud P, Cadranel J, Crestani B, Jouneau S, Marchand-Adam S, Nunes H, Wémeau-Stervinou L, Bergot E, Blanchard E, Borie R, Bourdin A, Chenivesse C, Clément A, Gomez E, Gondouin A, Hirschi S, Lebargy F, Marquette CH, Montani D, Prévot G, Quetant S, Reynaud-Gaubert M, Salaun M, Sanchez O, Trumbic B, Berkani K, Brillet PY, Campana M, Chalabreysse L, Chatté G, Debieuvre D, Ferretti G, Fourrier JM, Just N, Kambouchner M, Legrand B, Le Guillou F, Lhuillier JP, Mehdaoui A, Naccache JM, Paganon C, Rémy-Jardin M, Si-Mohamed S, Terrioux P; OrphaLung network.

Respir Med Res. 2023 Jun;83:100948.
Hypertension pulmonaire (HTP) 31/08/23
Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Lechartier B, Kularatne M, Jaïs X, Humbert M, Montani D.

Semin Respir Crit Care Med. 2023 Aug 18.
Hypertension pulmonaire (HTP) 31/08/23
Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.

Olsson KM, Corte TJ, Kamp JC, Montani D, Nathan SD, Neubert L, Price LC, Kiely DG.

Lancet Respir Med. 2023 Aug 14:S2213-2600(23)00259-X.
Hypertension pulmonaire (HTP) 31/08/23
Diagnosis and management of pulmonary veno-occlusive disease.

Solinas S, Boucly A, Beurnier A, Kularatne M, Grynblat J, Eyries M, Dorfmüller P, Sitbon O, Humbert M, Montani D.

Expert Rev Respir Med. 2023 Aug 21:1-15.
Hypertension pulmonaire (HTP) 31/08/23
[Physiopathology and treatment of pulmonary arterial hypertension].

Perros F, Jutant ÉM, Savale L, Dorfmüller P, Humbert M, Montani D.

Med Sci (Paris). 2023 Apr;39(4):359-369.
Hypertension pulmonaire (HTP) 31/08/23
Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.

Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M.

Circulation. 2023 Jun 13;147(24):1809-1822.
Hypertension pulmonaire (HTP) 31/08/23
Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.

Sanges S, Rice L, Tu L, Valenzi E, Cracowski JL, Montani D, Mantero JC, Ternynck C, Marot G, Bujor AM, Hachulla E, Launay D, Humbert M, Guignabert C, Lafyatis R.

Ann Rheum Dis. 2023 Mar;82(3):365-373.
Hypertension pulmonaire (HTP) 31/08/23
Pulmonary arterial hypertension

Boucly A, Gerges C, Savale L, Jaïs X, Jevnikar M, Montani D, Sitbon O, Humbert M

Presse Med. 2023 Jul 27:104168.

FILTRER :

Par mot clé

Par maladies

Réinitialiser les filtres

Physiological and pathophysiological roles of the KCNK3 potassium channel in the pulmonary circulation and the heart.

Isolated Pulmonary Arteriovenous Malformations Associated With BMPR2 Pathogenic Variants.

French practical guidelines for the diagnosis and management of idiopathic pulmonary fibrosis – 2021 update. Full-length version.

Updated Hemodynamic Definition and Classification of Pulmonary Hypertension.

Pulmonary hypertension associated with lung disease: new insights into pathomechanisms, diagnosis, and management.

Diagnosis and management of pulmonary veno-occlusive disease.

[Physiopathology and treatment of pulmonary arterial hypertension].

Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension.

Biomarkers of haemodynamic severity of systemic sclerosis-associated pulmonary arterial hypertension by serum proteome analysis.

Pulmonary arterial hypertension